SENS Share Price Performance
US$0.46
0.06 (14.30%)
70.1% undervalued intrinsic discount
US$1.55
Fair Value
Price US$0.46
AnalystConsensusTarget US$1.55
Fair ValueUS$1.55
Share PriceUS$0.46
70.1% undervalued intrinsic discount
SENS Community Narratives
AN
Fair Value US$1.55 70.1% undervalued intrinsic discount
Eversense 365 Will Expand Patient Access With EU Launch
1users have liked this narrative
3users have commented on this narrative
22users have followed this narrative
Recent SENS News & Updates
No updates
Senseonics Holdings, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.091
- Gross Margin
- 7.19%
- Net Profit Margin
- -312.47%
- Debt/Equity Ratio
- 99.3%
Senseonics Holdings, Inc. Competitors
About SENS
- Founded
- 1996
- Employees
- 117
- CEO
- WebsiteView website
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company’s products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland.
U.S. Market Performance
- 7 Days: -0.2%
- 3 Months: 12.2%
- 1 Year: 22.4%
- Year to Date: 7.7%
The Communication Services sector gained 3.4% while the market remained flat over the last week. More promisingly, the market is up 22% over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading